Executive summary
- 1 July 2009
- journal article
- review article
- Published by Wiley in Xenotransplantation
- Vol. 16 (4) , 196-202
Abstract
Abstract: The International Xenotransplantation Association islet xenotransplantation consensus statement describes the conditions for undertaking clinical trials of porcine islet products in type 1 diabetes. Chapter 1 reviews the key ethical requirements and progress toward the definition of an international regulatory framework for clinical trials of xenotransplantation. Chapters 2 to 7 provide in depth and agreed‐upon recommendations on source pigs, pig islet product manufacturing and release testing, preclinical efficacy and complication data required to justify a clinical trial, strategies to prevent transmission of porcine endogenous retrovirus, patient selection for clinical trials, and informed consent. It is planned to update this initial consensus statement in a year's time in light of progress in research, changes in the regulatory framework, and comments submitted after publication.Keywords
This publication has 19 references indexed in Scilit:
- Chapter 4: Pre‐clinical efficacy and complication data required to justify a clinical trialXenotransplantation, 2009
- Chapter 2: Source pigsXenotransplantation, 2009
- Chapter 6: Patient selection for pilot clinical trials of islet xenotransplantationXenotransplantation, 2009
- Chapter 3: Pig islet product manufacturing and release testingXenotransplantation, 2009
- Chapter 7: Informed consent and xenotransplantation clinical trialsXenotransplantation, 2009
- Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate modelProceedings of the National Academy of Sciences, 2009
- A Consensus Document based on the Pig-to-Man Islet Transplant Summit held in Stockholm, June 4–5, 2007Xenotransplantation, 2008
- Proceedings of "Pig-to-Man Islet Transplant Summit" held at the Nobel Forum, Stockholm, June 4–5, 2007Xenotransplantation, 2008
- Islet Xenotransplantation: Are We Really Ready for Clinical Trials?American Journal of Transplantation, 2006
- Selected food and drug administration review issues for regulation of allogeneic islets of langerhans as somatic cell therapyTransplantation, 2002